About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Astrazeneca Pharma India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
332.64
NSE Code
ASTRAZEN
Dividend Yield %
0.37
Market Cap
217951.25
P/E
108.49
EPS
80.36
Face Value
2
BSE
NSE
13-Apr-2026
BSE
NSE
NSE F & O
13-Apr-2026
BSE
NSE
NSE F & O
Last Price
8718.05
Net Change
426.55
% Change
5.14%
Prev.Close
8291.50
Open
8298.25
High
8860.00
Low
8002.00
Volume
1424
Last Price
8725.00
Net Change
426
% Change
5.13%
Prev.Close
8299.00
Open
8024.50
High
8895.00
Low
8024.00
Volume
55429
Value
12267565
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
8860.00
52-Week High
10653.05
52-Week Low
7630.00
Value
480420533.5
Best Buy
8725.00
Best Sell
0.00
Best Quantity
211
Sell Quantity
0
Today's Range
8895.00
52-Week High
10691.00
52-Week Low
7551.50
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
211
Price
8725.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
03-Sep-18
10-Sep-18
Dividend
1600 %
18-Jul-25
Company News
13-04-2026
AstraZeneca Pharma gets n...
13-04-2026
AstraZeneca Pharma surges...
17-03-2026
AstraZeneca Pharma gets n...
11-03-2026
AstraZeneca Pharma India ...
27-02-2026
AstraZeneca Pharma India ...
10-02-2026
AstraZeneca Pharma gets C...
10-02-2026
AstraZeneca Pharma India ...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.